Kingworld Medicines Group Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 957.7 million compared to CNY 847.39 million a year ago. Net income was CNY 22.74 million compared to CNY 30.32 million a year ago.

Basic earnings per share from continuing operations was CNY 0.0375 compared to CNY 0.05 a year ago. Diluted earnings per share from continuing operations was CNY 0.0375 compared to CNY 0.05 a year ago.